Enhancing AAV Production: A Novel Transfection System For Cell And Gene Therapy Applications

The increasing demand for adeno-associated virus (AAV) vectors for cell and gene therapy has highlighted the need for efficient and scalable production methods. To address these challenges, we invite you to a webinar introducing a groundbreaking transfection system designed to optimize AAV yield and quality.

Learn how the TransIT-AAViator AAV Transfection System can help you:

• Increase AAV titers: Achieve higher viral particle production for various indications.
• Improve AAV capsid quality: Ensure more complete and functional viral particles.
• Simplify production workflows: Streamline your AAV manufacturing process.

View this webinar to discover how Mirus Bio's latest transfection technology can revolutionize your AAV production.